• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

将透析护理从雇主市场转移到医疗保险的成本。

The Cost of Transferring Dialysis Care From the Employer-Based Market to Medicare.

机构信息

Division of Nephrology, Department of Medicine, University of Southern California, Los Angeles.

Leonard D Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles.

出版信息

JAMA Netw Open. 2021 Mar 1;4(3):e212113. doi: 10.1001/jamanetworkopen.2021.2113.

DOI:10.1001/jamanetworkopen.2021.2113
PMID:33734412
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7974636/
Abstract

This cohort study investigates the frequency and characteristics of patients with end-stage kidney disease receiving dialysis who prematurely transition from their employer-based group health plan to Medicare.

摘要

这项队列研究调查了接受透析的终末期肾病患者中，提前从雇主团体健康计划过渡到医疗保险的患者的频率和特征。

相似文献

1
The Cost of Transferring Dialysis Care From the Employer-Based Market to Medicare.将透析护理从雇主市场转移到医疗保险的成本。
JAMA Netw Open. 2021 Mar 1;4(3):e212113. doi: 10.1001/jamanetworkopen.2021.2113.
2
Does One Size Fit All With the Effects of Payment Reform? Dialysis Facility Payer Mix and Anemia Management Under the Expanded Medicare Prospective Payment System.支付方式改革的效果是否一刀切？扩大的 Medicare 前瞻性支付系统下的透析设施支付方组合和贫血管理。
Med Care. 2019 Aug;57(8):584-591. doi: 10.1097/MLR.0000000000001151.
3
Using race as a case-mix adjustment factor in a renal dialysis payment system: potential and pitfalls.在肾脏透析支付系统中使用种族作为病例组合调整因素：潜在问题与陷阱。
Am J Kidney Dis. 2010 Nov;56(5):928-36. doi: 10.1053/j.ajkd.2010.08.006.
4
Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system.在捆绑式前瞻性支付系统下改变透析方式组合对医疗保险的财务影响。
Perit Dial Int. 2014 Nov-Dec;34(7):749-57. doi: 10.3747/pdi.2013.00305. Epub 2014 Oct 7.
5
Medicare ESRD prospective payment system: weighing the evidence.医疗保险终末期肾病前瞻性支付系统：权衡证据
J Am Soc Nephrol. 2005 May;16(5):1164-5. doi: 10.1681/ASN.2005030315. Epub 2005 Apr 13.
6
The 2011 ESRD prospective payment system: welcome to the bundle.2011年终末期肾病前瞻性支付系统：欢迎加入捆绑支付。
Am J Kidney Dis. 2011 Apr;57(4):539-41. doi: 10.1053/j.ajkd.2011.01.007. Epub 2011 Feb 18.
7
Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, and End-Stage Renal Disease Quality Incentive Program. Final rule.医疗保险计划；终末期肾病前瞻性支付系统、向急性肾损伤患者提供的肾透析服务支付以及终末期肾病质量激励计划。最终规则。
Fed Regist. 2017 Nov 1;82(210):50738-97.
8
The 2011 ESRD prospective payment system: perspectives from Fresenius Medical Care, a large dialysis organization.2011年终末期肾病前瞻性支付系统：来自大型透析机构费森尤斯医疗集团的观点。
Am J Kidney Dis. 2011 Apr;57(4):547-9. doi: 10.1053/j.ajkd.2011.01.008. Epub 2011 Feb 17.
9
The 2011 ESRD prospective payment system: an uncontrolled experiment.2011年终末期肾病前瞻性支付系统：一项非对照实验。
Am J Kidney Dis. 2011 Apr;57(4):542-6. doi: 10.1053/j.ajkd.2011.01.013. Epub 2011 Feb 17.
10
The 2011 ESRD prospective payment system: perspectives from a for-profit small- to medium-sized dialysis organization.2011年终末期肾病前瞻性支付系统：一家营利性中小型透析机构的观点
Am J Kidney Dis. 2011 Apr;57(4):556-8. doi: 10.1053/j.ajkd.2011.01.012.

引用本文的文献

1
Insurance Transitions from Employer-Based Insurance to Medicare and Waitlisting for Kidney Transplantation: Placing Marietta v. DaVita in Context.从雇主提供的保险过渡到医疗保险以及肾脏移植等待名单：解读玛丽埃塔诉达维塔案
J Am Soc Nephrol. 2024 Apr 1;35(4):495-498. doi: 10.1681/ASN.0000000000000298. Epub 2024 Jan 15.
2
The Association of Dialysis Facility Payer Mix With Access to Kidney Transplantation.透析设施支付方组合与获得肾移植机会的关联。
JAMA Netw Open. 2023 Jul 3;6(7):e2322803. doi: 10.1001/jamanetworkopen.2023.22803.
3
Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study.主要心血管事件与后续肾脏替代治疗的衰竭风险：CKD 预后联盟研究。
Eur Heart J. 2023 Apr 1;44(13):1157-1166. doi: 10.1093/eurheartj/ehac825.
4
Assessment of Spending for Patients Initiating Dialysis Care.评估开始透析治疗的患者的支出。
JAMA Netw Open. 2022 Oct 3;5(10):e2239131. doi: 10.1001/jamanetworkopen.2022.39131.

本文引用的文献

1
Cost-effectiveness of multidisciplinary care in mild to moderate chronic kidney disease in the United States: A modeling study.多学科护理治疗美国轻中度慢性肾脏病的成本效益：一项建模研究。
PLoS Med. 2018 Mar 27;15(3):e1002532. doi: 10.1371/journal.pmed.1002532. eCollection 2018 Mar.
2
The effect of renal insufficiency on workforce participation in the United States: an analysis using National Health and Nutrition Examination Survey III data.肾功能不全对美国劳动力参与情况的影响：一项使用第三次全国健康与营养检查调查数据的分析
Am J Kidney Dis. 2002 Dec;40(6):1132-7. doi: 10.1053/ajkd.2002.36854.
3
Validation of comorbid conditions on the end-stage renal disease medical evidence report: the CHOICE study. Choices for Healthy Outcomes in Caring for ESRD.
J Am Soc Nephrol. 2000 Mar;11(3):520-529. doi: 10.1681/ASN.V113520.